<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107420">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01695863</url>
  </required_header>
  <id_info>
    <org_study_id>11042705</org_study_id>
    <nct_id>NCT01695863</nct_id>
  </id_info>
  <brief_title>Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep</brief_title>
  <official_title>Phase 4 of Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade
      versus Movi Prep for outpatient colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study is the purpose of evaluating patient satisfaction and at the same time efficacy of the
      bowel regimen in cleansing the colon
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>bowel prep efficacy</measure>
    <time_frame>8 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the bowel prep efficacy in cleansing the colon for colonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assess change in renal function pre and post bowel prep</measure>
    <time_frame>8 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>changes in electrolytes pre and post bowel preparation administration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>miralax</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>miralax with dulcolax and gatorade efficacy evaluated by colonoscopy and patient satisfaction evaluated by patient questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moviprep split dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Efficacy of split dose moviprep on cleansing colon for colonoscopy and patient satisfaction with the regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparing 2 drugs on their effect on the bowel preparation for colonoscopy</intervention_name>
    <description>the effects of the drug on the colon preparation for colonoscopy</description>
    <arm_group_label>miralax</arm_group_label>
    <arm_group_label>moviprep split dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  outpatient colonoscopy for screening for other Gi related problems

        Exclusion Criteria:

          -  Severe CHF,

          -  CKD,

          -  less than age 18 or more than 80 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maqsood A Khan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Keshavarzian, MD</last_name>
    <role>Study Chair</role>
    <affiliation>RUMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael D Brown, MD</last_name>
    <role>Study Director</role>
    <affiliation>RUMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John losurdo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush Unversity Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://rush.edu</url>
    <description>rush university medical center website</description>
  </link>
  <reference>
    <citation>Rex DK, Imperiale TF, Latinovich DR, Bratcher LL. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol. 2002 Jul;97(7):1696-700.</citation>
    <PMID>12135020</PMID>
  </reference>
  <reference>
    <citation>Hookey LC, Vanner S. A review of current issues underlying colon cleansing before colonoscopy. Can J Gastroenterol. 2007 Feb;21(2):105-11. Review.</citation>
    <PMID>17299615</PMID>
  </reference>
  <reference>
    <citation>DiPalma JA, Wolff BG, Meagher A, Cleveland M. Comparison of reduced volume versus four liters sulfate-free electrolyte lavage solutions for colonoscopy colon cleansing. Am J Gastroenterol. 2003 Oct;98(10):2187-91.</citation>
    <PMID>14572566</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 20, 2013</lastchanged_date>
  <firstreceived_date>August 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Maqsood Khan</investigator_full_name>
    <investigator_title>GI fellow</investigator_title>
  </responsible_party>
  <keyword>Miralax with gatorade and dulcolax</keyword>
  <keyword>Movi pre</keyword>
  <keyword>Patient satisfaction and efficacy</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
